Drug:
Reaction: ADVERSE DRUG REACTION
20260101 - 20261231
No. 301 - 400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 301 | 26462455 |
US |
2 | |
Adverse drug reaction, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 302 | 26462616 |
CA |
85 | 1 |
Blood calcium decreased, Blood phosphorus decreased, Adverse drug reaction, |
||||
ZOLEDRONIC ACID, GOSERELIN, GOSERELIN, GOSERELIN, |
||||
| 303 | 26462788 |
2 | ||
Pneumonia, Adverse drug reaction, Therapy cessation, |
||||
RIBOCICLIB, |
||||
| 304 | 26463126 |
CA |
71 | 2 |
Non-Hodgkin^s lymphoma recurrent, Adverse drug reaction, |
||||
ZOLEDRONIC ACID, ZOLEDRONIC ACID, |
||||
| 305 | 26463510 |
RU |
1 | |
Adverse drug reaction, |
||||
PALIPERIDONE, |
||||
| 306 | 26463772 |
EU |
57 | 2 |
Death, Breath sounds abnormal, Malignant neoplasm progression, Flatulence, Hepatomegaly, Deep vein thrombosis, Weight decreased, Malignant neoplasm progression, Hypertension, Vein collapse, Poor peripheral circulation, Dry skin, Pneumonitis, Asthenia, Cardiac murmur, Pathological fracture, Oedema peripheral, Pleural effusion, Pleural effusion, Abdominal rigidity, Vomiting, Pulmonary embolism, Osteoporosis, Mucosal dryness, Nausea, Ascites, Ileus, Thrombocytopenia, Rheumatoid arthritis, Eyelid sensory disorder, Euphoric mood, Diarrhoea, Gastroenteritis viral, Dysgeusia, Blood urea increased, Psychomotor hyperactivity, Blood thyroid stimulating hormone decreased, Blood thyroid stimulating hormone increased, Insomnia, Headache, Headache, Suspected COVID-19, Pyrexia, Otitis media, Feeling abnormal, Vitiligo, Nausea, Nail discolouration, Skin depigmentation, Nausea, Nausea, Peripheral swelling, Tooth fracture, Swelling, Nasopharyngitis, Pain in extremity, Heart rate increased, Vitreous floaters, Tinnitus, Pyrexia, Pyrexia, Pyrexia, Tooth deposit, Muscular weakness, Pituitary tumour benign, Headache, Paraesthesia, Vertigo, Vein disorder, Confusional state, Benign mediastinal neoplasm, Influenza like illness, Mediastinal cyst, Urinary tract infection, Dyspepsia, Oral fungal infection, Alanine aminotransferase increased, Aspartate aminotransferase increased, Hepatic enzyme increased, Aspartate aminotransferase increased, Alanine aminotransferase increased, Gamma-glutamyltransferase increased, Blood thyroid stimulating hormone increased, Alanine aminotransferase increased, Diarrhoea, Hepatic enzyme increased, Product use issue, Adverse drug reaction, Circumstance or information capable of leading to medication error, Inappropriate schedule of product administration, Product dose omission issue, Product dose omission issue, |
||||
METHOTREXATE, METHOTREXATE SODIUM, PEMETREXED DISODIUM, PEMETREXED DISODIUM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, HYDROXYCHLOROQUINE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, |
||||
| 307 | 26463961 |
US |
49 | 2 |
Device difficult to use, Migraine, Adverse drug reaction, |
||||
ERENUMAB-AOOE, |
||||
| 308 | 26467793 |
61 | 1 | |
Adverse drug reaction, Therapy change, Therapy cessation, Pain, Nausea, Constipation, Diarrhoea, Fatigue, Flatulence, Abdominal distension, Hypophagia, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, CALCIUM, MAGNESIUM, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOPROLOL TARTRATE, METOPROLOL, ISOSORBIDE DINITRATE, HYDROCHLOROTHIAZIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 309 | 26468175 |
57 | 1 | |
Adverse drug reaction, Urticaria, Dyspnoea, |
||||
| 310 | 26457072 |
US |
||
Adverse drug reaction, |
||||
MAVACAMTEN, |
||||
| 311 | 26457207 |
US |
||
Adverse drug reaction, Product availability issue, Product use in unapproved indication, |
||||
ZONISAMIDE, ZONISAMIDE, LACOSAMIDE, |
||||
| 312 | 26457349 |
EU |
2 | |
Breast cancer recurrent, Drug intolerance, Adverse drug reaction, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, EXEMESTANE, |
||||
| 313 | 26457484 |
US |
59 | 2 |
Adverse drug reaction, |
||||
ABATACEPT, |
||||
| 314 | 26457724 |
US |
||
Headache, Adverse drug reaction, |
||||
ESCITALOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, |
||||
| 315 | 26458446 |
US |
||
Adverse drug reaction, |
||||
MAVACAMTEN, |
||||
| 316 | 26458625 |
|||
Drug ineffective, Adverse drug reaction, Off label use, |
||||
BIMEKIZUMAB, SECUKINUMAB, LOSARTAN POTASSIUM, LOSARTAN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, FUROSEMIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, SECUKINUMAB, CERTOLIZUMAB PEGOL, PREDNISONE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, CALCIUM POLYCARBOPHIL, BUDESONIDE, TOFACITINIB, UPADACITINIB, RISANKIZUMAB-RZAA, GOLIMUMAB, BIMEKIZUMAB, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, SERTRALINE HYDROCHLORIDE, |
||||
| 317 | 26459373 |
19 | ||
Staphylococcal infection, Adverse drug reaction, |
||||
BIMEKIZUMAB, |
||||
| 318 | 26459545 |
JP |
22 | 1 |
Henoch-Schonlein purpura, Adverse drug reaction, Crohn^s disease, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, UPADACITINIB, |
||||
| 319 | 26459837 |
|||
Pyrexia, Pain, Product dose omission issue, Device issue, Adverse drug reaction, Drug ineffective, Product availability issue, |
||||
BIMEKIZUMAB, DULOXETINE HYDROCHLORIDE, DULOXETINE, PHENTERMINE HYDROCHLORIDE, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE GEL USP, 1%, CLINDAMYCIN PHOSPHATE TOPICAL, GABAPENTIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, SULFASALAZINE, AMITRIPTYLINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE, |
||||
| 320 | 26460027 |
47 | ||
Oral candidiasis, Condition aggravated, Peripheral swelling, Dysphonia, Oropharyngeal discomfort, Oropharyngeal pain, Throat tightness, Adverse drug reaction, Dysphagia, |
||||
BIMEKIZUMAB, DICLOFENAC SODIUM, ESZOPICLONE, FLUCONAZOLE, ATORVASTATIN CALCIUM, BUPROPION HYDROCHLORIDE, RIVAROXABAN, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, SERTRALINE, CLONAZEPAM, |
||||
| 321 | 26460214 |
2 | ||
Adverse drug reaction, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 322 | 26462896 |
67 | 1 | |
Adverse drug reaction, |
||||
DABIGATRAN ETEXILATE MESYLATE, DABIGATRAN ETEXILATE, |
||||
| 323 | 26452940 |
US |
||
Adverse drug reaction, |
||||
UPADACITINIB, |
||||
| 324 | 26453152 |
CH |
||
Adverse drug reaction, Overdose, |
||||
METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, |
||||
| 325 | 26453511 |
US |
||
Adverse drug reaction, |
||||
ISOTRETINOIN, |
||||
| 326 | 26453585 |
US |
63 | 1 |
Therapeutic product effect decreased, Adverse drug reaction, |
||||
ADALIMUMAB, ADALIMUMAB, PREDNISONE, ZOLEDRONIC ACID, |
||||
| 327 | 26454069 |
61 | ||
Adverse drug reaction, |
||||
BIMEKIZUMAB, |
||||
| 328 | 26454492 |
US |
2 | |
Adverse drug reaction, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 329 | 26454533 |
CA |
60 | 2 |
Sleeve gastrectomy, Adverse drug reaction, Drug ineffective, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, ALBUTEROL SULFATE, ALBUTEROL, HYDROCHLOROTHIAZIDE, PREDNISONE, |
||||
| 330 | 26454730 |
CA |
44 | 2 |
Stomatitis, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Therapeutic product effect decreased, Therapy non-responder, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Rash, Wheezing, Wound, Joint swelling, Abdominal pain, Abdominal pain upper, Adverse drug reaction, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthropathy, Asthenia, Asthma, Autoimmune disorder, Blister, Blood cholesterol increased, Bursitis, C-reactive protein abnormal, Chest pain, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Diarrhoea, Discomfort, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspnoea, Exposure during pregnancy, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Hand deformity, Headache, Helicobacter infection, Hepatic cirrhosis, Hepatic enzyme increased, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Insomnia, Intentional product use issue, Irritable bowel syndrome, Joint dislocation, Joint range of motion decreased, Lip dry, Liver disorder, Liver injury, Lower limb fracture, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Maternal exposure timing unspecified, Medication error, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nasopharyngitis, Night sweats, Obesity, Oedema, Oedema peripheral, Off label use, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pregnancy, Prescribed overdose, Product use in unapproved indication, Product use issue, Pruritus, Psoriatic arthropathy, Pyrexia, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sciatica, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, OXYCODONE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, ADALIMUMAB-ADAZ, OXYCODONE HYDROCHLORIDE, OXYCODONE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, AZATHIOPRINE, CELECOXIB, CELECOXIB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SECUKINUMAB, LEFLUNOMIDE, LEFLUNOMIDE, VITAMIN C, CALCIUM CARBONATE, ANTACID, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CALCIUM GLUCONATE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, CORTISONE ACETATE, CORTISONE ACETATE, DEXTROMETHORPHAN, DEXTROMETHORPHAN, GOLIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE BUTYRATE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, ERGOCALCIFEROL, MORPHINE SULFATE, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, LISINOPRIL, LISINOPRIL, RAMIPRIL, SULFASALAZINE, TOFACITINIB, LANSOPRAZOLE, LANSOPRAZOLE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, LORAZEPAM, TRIMETHOPRIM, CAFFEINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ERGOCALCIFEROL, ERGOCALCIFEROL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, LORAZEPAM, LORAZEPAM, |
||||
| 331 | 26455278 |
US |
1 | |
Adverse drug reaction, |
||||
KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, |
||||
| 332 | 26455316 |
2 | ||
Blood pressure increased, Adverse drug reaction, Dysgeusia, Parosmia, Hypophagia, |
||||
PEMBROLIZUMAB, AXITINIB, AMLODIPINE, |
||||
| 333 | 26455367 |
US |
55 | 2 |
Injection site reaction, Malaise, Adverse drug reaction, Eye pruritus, Back pain, Urticaria, Vertigo, Headache, Pruritus, Feeling abnormal, Skin lesion, Product use issue, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, BENRALIZUMAB, BENRALIZUMAB, |
||||
| 334 | 26455694 |
US |
1 | |
Adverse drug reaction, Cardiac dysfunction, Pulmonary congestion, Aspiration, |
||||
VALSARTAN, VALSARTAN ORAL, SACUBITRIL AND VALSARTAN, |
||||
| 335 | 26458574 |
|||
Adverse drug reaction, |
||||
RITUXIMAB, |
||||
| 336 | 26448505 |
US |
||
Adverse drug reaction, |
||||
VALSARTAN, VALSARTAN ORAL, |
||||
| 337 | 26448759 |
|||
Myasthenia gravis, Adverse drug reaction, |
||||
ROZANOLIXIZUMAB, |
||||
| 338 | 26449081 |
|||
Adverse drug reaction, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 339 | 26449270 |
US |
79 | 2 |
Adverse drug reaction, |
||||
LENALIDOMIDE, |
||||
| 340 | 26449431 |
US |
62 | 2 |
Adverse drug reaction, |
||||
POMALIDOMIDE, |
||||
| 341 | 26449577 |
58 | ||
Ankylosing spondylitis, Injection site discharge, Adverse drug reaction, Product dose omission issue, |
||||
BIMEKIZUMAB, |
||||
| 342 | 26449682 |
US |
1 | |
Adverse drug reaction, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 343 | 26450593 |
US |
2 | |
Neoplasm malignant, Stress, Adverse drug reaction, Injection site pain, |
||||
FULVESTRANT, FULVESTRANT, |
||||
| 344 | 26450715 |
34 | 2 | |
Adverse drug reaction, Drug intolerance, |
||||
EZETIMIBE, EVOLOCUMAB, |
||||
| 345 | 26450736 |
US |
2 | |
Adverse drug reaction, |
||||
ONABOTULINUMTOXINA, |
||||
| 346 | 26451436 |
2 | ||
Adverse drug reaction, |
||||
| 347 | 26451584 |
|||
Adverse drug reaction, |
||||
ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, |
||||
| 348 | 26452049 |
|||
Adverse drug reaction, Morphoea, Pruritus, |
||||
ZILUCOPLAN, PYRIDOSTIGMINE BROMIDE, |
||||
| 349 | 26454977 |
76 | 1 | |
Fungal infection, Adverse drug reaction, |
||||
CABAZITAXEL, |
||||
| 350 | 26455473 |
71 | 1 | |
Conjunctival oedema, Adverse drug reaction, |
||||
| 351 | 26446165 |
US |
||
Thyroid hormones increased, Anxiety, Fatigue, Seasonal affective disorder, Adverse drug reaction, |
||||
RISANKIZUMAB-RZAA, |
||||
| 352 | 26447039 |
US |
2 | |
Adverse drug reaction, |
||||
DUPILUMAB, |
||||
| 353 | 26447757 |
US |
67 | 2 |
Adverse drug reaction, Off label use, |
||||
DUPILUMAB, |
||||
| 354 | 26448135 |
US |
2 | |
Alopecia, Adverse drug reaction, |
||||
PEMBROLIZUMAB, |
||||
| 355 | 26441222 |
GB |
||
Depressed level of consciousness, Drug ineffective, Adverse drug reaction, Product shape issue, Suspected counterfeit product, |
||||
DEXTROAMPHETAMINE SULFATE, |
||||
| 356 | 26441247 |
US |
||
Adverse drug reaction, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 357 | 26441458 |
US |
77 | 2 |
Asthenia, Disturbance in attention, Adverse drug reaction, |
||||
PIMAVANSERIN TARTRATE, MEMANTINE, MEMANTINE HYDROCHLORIDE, GABAPENTIN, PATIROMER, DONEPEZIL HYDROCHLORIDE, CARBIDOPA AND LEVODOPA, LORAZEPAM, CYCLOBENZAPRINE, CAPTOPRIL, HYDRALAZINE HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 358 | 26441523 |
US |
||
Adverse drug reaction, Drug effect less than expected, Low density lipoprotein abnormal, Blood cholesterol abnormal, |
||||
EVOLOCUMAB, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, |
||||
| 359 | 26441837 |
US |
73 | 2 |
Headache, Palpitations, Adverse drug reaction, |
||||
ROMOSOZUMAB-AQQG, ZOLEDRONIC ACID, |
||||
| 360 | 26441886 |
US |
||
Adverse drug reaction, |
||||
ACALABRUTINIB, |
||||
| 361 | 26442282 |
US |
74 | 1 |
Syncope, Adverse drug reaction, Diplopia, Vision blurred, Blood uric acid decreased, Overdose, |
||||
PEGLOTICASE, PEGLOTICASE, |
||||
| 362 | 26442832 |
US |
||
Adverse drug reaction, |
||||
TROFINETIDE, |
||||
| 363 | 26442903 |
US |
||
Adverse drug reaction, |
||||
TROFINETIDE, |
||||
| 364 | 26443165 |
US |
||
Infection, Adverse drug reaction, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 365 | 26443651 |
CA |
63 | 2 |
Adverse drug reaction, Asthma, Blood immunoglobulin E increased, Chest discomfort, Chronic sinusitis, Cough, Dysphonia, Dyspnoea, Emotional distress, Eosinophilia, Ill-defined disorder, Laryngeal dyskinesia, Laryngeal stenosis, Loss of personal independence in daily activities, Middle insomnia, Muscle spasms, Obstructive airways disorder, Sinus disorder, Skin lesion, Sleep disorder, Wheezing, |
||||
MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, VALACYCLOVIR HYDROCHLORIDE, ALBUTEROL SULFATE, CICLESONIDE, BUDESONIDE, PANTOPRAZOLE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 366 | 26444147 |
US |
2 | |
Adverse drug reaction, Chemotherapy, |
||||
VOCLOSPORIN, |
||||
| 367 | 26445038 |
US |
||
Adverse drug reaction, |
||||
APALUTAMIDE, |
||||
| 368 | 26445770 |
CA |
2 | |
Hyperthyroidism, Adverse drug reaction, Inappropriate schedule of product administration, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 369 | 26445906 |
US |
||
Drug ineffective, Adverse drug reaction, |
||||
ONABOTULINUMTOXINA, |
||||
| 370 | 26452395 |
61 | 1 | |
Diabetic ketoacidosis, Adverse drug reaction, |
||||
EMPAGLIFLOZIN, |
||||
| 371 | 26436369 |
CA |
63 | 2 |
Laryngeal stenosis, Cough, Emotional distress, Adverse drug reaction, Muscle spasms, Dyspnoea, Asthma, Ill-defined disorder, Eosinophilia, Blood immunoglobulin E increased, Middle insomnia, Sinus disorder, Obstructive airways disorder, Laryngeal dyskinesia, Skin lesion, Chronic sinusitis, Chest discomfort, Wheezing, Dysphonia, Sleep disorder, Loss of personal independence in daily activities, |
||||
BUDESONIDE, PANTOPRAZOLE, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, VALACYCLOVIR HYDROCHLORIDE, CICLESONIDE, ALBUTEROL SULFATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, |
||||
| 372 | 26436729 |
US |
1 | |
Hallucination, Dizziness, Swollen tongue, Feeling abnormal, Adverse drug reaction, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 373 | 26436831 |
US |
51 | 2 |
Hysterectomy, Precancerous condition, Immunodeficiency, Pruritus, Asthenia, Therapeutic response shortened, Condition aggravated, Arthralgia, Inappropriate schedule of product administration, Adverse drug reaction, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB, |
||||
| 374 | 26437068 |
US |
1 | |
Adverse drug reaction, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 375 | 26437736 |
US |
||
Adverse drug reaction, |
||||
ISOTRETINOIN, ISOTRETINOIN, |
||||
| 376 | 26437773 |
US |
1 | |
Adverse drug reaction, |
||||
ONABOTULINUMTOXINA, |
||||
| 377 | 26437993 |
US |
||
Adverse drug reaction, |
||||
MAVACAMTEN, |
||||
| 378 | 26438629 |
US |
30 | 2 |
Product use in unapproved indication, Adverse drug reaction, |
||||
DELGOCITINIB, |
||||
| 379 | 26439244 |
US |
1 | |
Adverse drug reaction, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 380 | 26439519 |
US |
1 | |
Sensory disturbance, Adverse drug reaction, Drug ineffective, |
||||
LEVODOPA, CARBIDOPA AND LEVODOPA, |
||||
| 381 | 26440085 |
US |
||
Arthralgia, Illness, Adverse drug reaction, |
||||
USTEKINUMAB, USTEKINUMAB, |
||||
| 382 | 26440238 |
US |
||
Oesophageal varices haemorrhage, Central venous catheterisation, Adverse drug reaction, Fatigue, Spider naevus, Hypoxia, Headache, Cough, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, EMPAGLIFLOZIN, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, ANASTROZOLE, ANASTROZOLE TABLETS, RIFAXIMIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ERGOCALCIFEROL, SPIRONOLACTONE, OXYGEN, 0XYGEN, CARVEDILOL, TORSEMIDE, TREPROSTINIL, INSULIN HUMAN, SEMAGLUTIDE, ORAL SEMAGLUTIDE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, INSULIN GLARGINE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, MAGNESIUM CHLORIDE, EPOPROSTENOL, THIAMINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, |
||||
| 383 | 26440799 |
EU |
||
Adverse drug reaction, |
||||
SEMAGLUTIDE, |
||||
| 384 | 26440834 |
52 | 2 | |
Adverse drug reaction, |
||||
LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL, |
||||
| 385 | 26440930 |
US |
||
Adverse drug reaction, |
||||
ESCITALOPRAM, |
||||
| 386 | 26431871 |
US |
1 | |
Adverse drug reaction, Dizziness, Urinary tract infection, Fungal infection, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 387 | 26431899 |
2 | ||
Adverse drug reaction, |
||||
ROZANOLIXIZUMAB, |
||||
| 388 | 26432093 |
US |
86 | 2 |
Adverse drug reaction, |
||||
BRENSOCATIB, AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL, ESTRADIOL ACETATE, FLUTICASONE PROPIONATE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 389 | 26432673 |
US |
65 | 2 |
Adverse drug reaction, |
||||
DEUCRAVACITINIB, |
||||
| 390 | 26432922 |
US |
2 | |
Oxygen saturation decreased, Productive cough, Fatigue, Condition aggravated, Adverse drug reaction, |
||||
BRENSOCATIB, ALBUTEROL SULFATE, ALBUTEROL, ROSUVASTATIN, PREDNISONE, PANTOPRAZOLE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, MELATONIN, ERGOCALCIFEROL, REVEFENACIN, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, |
||||
| 391 | 26434726 |
|||
Adverse drug reaction, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 392 | 26434821 |
US |
35 | 2 |
Hyperhidrosis, Tremor, Feeling hot, Fatigue, Muscle tightness, Dyspnoea, Adverse drug reaction, |
||||
BRENSOCATIB, ALBUTEROL SULFATE, ALBUTEROL, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, ERGOCALCIFEROL, VITAMIN C, IRON, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, FERROUS SULFATE, GUAIFENESIN, |
||||
| 393 | 26434910 |
US |
82 | 1 |
Full blood count decreased, Adverse drug reaction, |
||||
POMALIDOMIDE, |
||||
| 394 | 26435453 |
US |
58 | 1 |
Adverse drug reaction, Product use in unapproved indication, |
||||
| 395 | 26436110 |
US |
||
Adverse drug reaction, |
||||
ISOTRETINOIN, |
||||
| 396 | 26436112 |
US |
||
Adverse drug reaction, Drug ineffective, |
||||
ISOTRETINOIN, ISOTRETINOIN, |
||||
| 397 | 26436113 |
US |
||
Therapy cessation, Adverse drug reaction, |
||||
ISOTRETINOIN, ISOTRETINOIN, |
||||
| 398 | 26436172 |
US |
72 | 1 |
Adverse drug reaction, Off label use, Drug intolerance, General physical health deterioration, |
||||
PEMBROLIZUMAB, |
||||
| 399 | 26436284 |
GB |
2 | |
Adverse drug reaction, Incorrect dose administered, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 400 | 26440216 |
1 | ||
Defiant behaviour, Therapy non-responder, Drug interaction, Adverse drug reaction, |
||||
METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, SERTRALINE HYDROCHLORIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28